nexmectin
Commercial- Indications
- Equine parasitic infections
Company intelligence / Profile preview
Audevard has over thirty years of expertise as the only European pharmaceutical laboratory dedicated exclusively to equine health. Its portfolio includes pharmaceuticals such as Tildren and Equioxx for bone/joint disorders and pain management; Ekyflogyl for anti-inflammatory needs; Imaverol for dermatological conditions; plus a wide range of supplements like Ekyflex and Ekygard. Products are distributed through veterinarians across Europe and worldwide. The company emphasizes quality ingredients, anti-doping compliance, and holistic horse care. No clinical trial data typical of human pharma companies—products are veterinary medicines or supplements.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Audevard.